Clinical Trial Update: Efficacy and Safety With Albumin-bound Paclitaxel (Abraxane) in the TAC as Neoadjuvant Chemotherapy in Breast Cancer [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update discussing the efficacy and safety of Abraxane (paclitaxel albumin-bound) in the TAC regimen as neoadjuvant chemotherapy for breast canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)

Snippet

Sponsor: Tianjin Medical University | Conditions: Breast Cancer | Phase 2, Phase 3 | Status: UNKNOWN